Collagen-binding peptide reverses bone loss in a mouse model of cerebral palsy based on clinical databases.

Shin, Yoon-Kyum et al.·Annals of physical and rehabilitation medicine·2021·Moderate EvidenceAnimal StudyAnimal Study
RPEP-05758Animal StudyModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
N=119 patients + 140 mice
Participants
119 cerebral palsy patients, 13 healthy controls (clinical); 140 mice with hypoxic-ischemic brain injury CP model (preclinical)

What This Study Found

Collagen-binding peptide increased trabecular thickness, collagen content, and osteoblast differentiation markers (RUNX2, osteocalcin) in a CP mouse model developed from clinical transcriptome analysis of 119 CP patients.

Key Numbers

119 CP patients; SPP1 downregulated; 140 mice; CBP increased trabecular thickness, collagen, bone turnover; RUNX2 and osteocalcin upregulated vs saline

How They Did This

Translational study: transcriptome analysis of 119 CP patients and 13 healthy controls, development of a hypoxic-ischemic brain injury CP mouse model (140 mice), and testing of collagen-binding peptide vs saline control.

Why This Research Matters

Bone loss in cerebral palsy causes fractures and pain but has no approved drug treatment. A peptide that directly stimulates bone building could fill this critical gap.

What This Study Doesn't Tell Us

Mouse model may not fully replicate human CP bone loss. The collagen-binding peptide was tested only short-term. No comparison to existing osteoporosis drugs. Human clinical trials are needed.

Trust & Context

Original Title:
Collagen-binding peptide reverses bone loss in a mouse model of cerebral palsy based on clinical databases.
Published In:
Annals of physical and rehabilitation medicine, 64(3), 101445 (2021)
Database ID:
RPEP-05758

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-05758·https://rethinkpeptides.com/research/RPEP-05758

APA

Shin, Yoon-Kyum; Heo, Jeong Hyun; Lee, Jue Yeon; Park, Yoon-Jeong; Cho, Sung-Rae. (2021). Collagen-binding peptide reverses bone loss in a mouse model of cerebral palsy based on clinical databases.. Annals of physical and rehabilitation medicine, 64(3), 101445. https://doi.org/10.1016/j.rehab.2020.09.009

MLA

Shin, Yoon-Kyum, et al. "Collagen-binding peptide reverses bone loss in a mouse model of cerebral palsy based on clinical databases.." Annals of physical and rehabilitation medicine, 2021. https://doi.org/10.1016/j.rehab.2020.09.009

RethinkPeptides

RethinkPeptides Research Database. "Collagen-binding peptide reverses bone loss in a mouse model..." RPEP-05758. Retrieved from https://rethinkpeptides.com/research/shin-2021-collagenbinding-peptide-reverses-bone

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.